Explore the Federal Circuit's exclusive authority over pharmaceutical patent cases, covering key precedents like Mylan, Hatch-Waxman disputes, and the impact on generic drug timelines.
Mar, 18 2025
Aug, 6 2026
Nov, 24 2025
Dec, 19 2025
Apr, 10 2026